Cartesian Therapeutics
RNAC
#7523
Rank
NZ$0.51 B
Marketcap
$20.03
Share price
11.28%
Change (1 day)
-8.31%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -NZ$0.13 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are NZ$38.91 Million. , an increase over its 2023 earnings that were of -NZ$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.14 Billion-67.3%
2023 -NZ$0.43 Billion-724%
2022 NZ$67.31 M-649.67%
2021 -NZ$12.25 Million-89.78%
2020 -NZ$0.12 Billion25.06%
2019 -NZ$95.87 Million-15.68%
2018 -NZ$0.12 Billion-0.43%
2017 -NZ$0.12 Billion83.41%
2016 -NZ$62.26 Million44.3%
2015 -NZ$43.15 Million